$24.95-0.06 (-0.24%)
Lifeway Foods, Inc.
Lifeway Foods, Inc. in the Consumer Defensive sector is trading at $24.95 with a market capitalization of $352M. Wall Street consensus targets $33.00 (3 analysts), implying a +32.3% move over the next 12 months. The stock is currently 27% below its 52-week high of $34.20, remaining 1.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $63.01M↑ | $55.36M↓ | $57.14M↑ | $53.90M↑ | $46.09M |
| Gross Profit | $17.35M↑ | $15.36M↓ | $16.41M↑ | $15.40M↑ | $11.04M |
| Operating Income | $6.33M↑ | $3.76M↓ | $5.04M↓ | $5.79M↑ | $1.57M |
| Net Income | $4.67M↑ | $2.54M↓ | $3.53M↓ | $4.25M↑ | $3.54M |
Lifeway Foods, Inc. produces and markets probiotic-based products in North America. The company's primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and milk types. It offers European-style...
Lifeway Foods Inc (LWAY) posts 27th consecutive quarter of growth with $66.9M in net sales, but margin compression from milk and resin costs weighs on profitability.

Lifeway Foods (NASDAQ:LWAY) reported record second-quarter net sales of $66.9 million, up 24.1% from the prior-year period, as higher volumes of its flagship kefir products and high-protein Farmer Cheese supported growth. President and Chief Executive Officer Julie Smolyansky said the quarter marke
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2026 investor letter. A copy of the letter is available to download here. In Q2 2026, the Micro Opportunities strategy underperformed the Russell Microcap Index, despite a positive absolute result. The benchmark performed well during a speculative period for micro caps. Over the […]
Lifeway's largest investor has called on the US kefir maker's shareholders to vote against the company's nominees for board roles at its annual meeting on 17 June.
The dairy giant is selling off its shares in the kefir maker, ending a long and tumultuous relationship between the two companies.